[Current problems of active substance research. 3. Structure-activity relationships of angiotensin II and analog].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D008954:Models, Biological; D008961:Models, Structural; D008968:Molecular Conformation; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology*; D010446:Peptide Fragments; D011311:Pressoreceptors / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013237:Stereoisomerism; D013270:Stomach / Q000187:drug effects; D013329:Structure-Activity Relationship; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D009842:Oligopeptides; D010446:Peptide Fragments; D014662:Vasoconstrictor Agents; D000804:Angiotensin II
Aktuelle Probleme der wirkstofforschung. 3. Struktur-Wirkungs-Beziehungen von Angiotensin II und Analogen